OmniCorder scores Italian install

Infrared imaging technology provider OmniCorder Technologies has delivered its BioScanIR system to Italy's National Tumor Institute in Milan, according to the East Setauket, NY-based vendor.

The specially configured system will be part of an international study to monitor breast cancer patients undergoing neoadjuvant cancer therapy, the company said.

By staff writers
October 15, 2004

Related Reading

OmniCorder finalizes name change, February 27, 2004

OmniCorder gets BioScanIR CE Mark, September 23, 2003

Thermal imaging market for breast cancer heats up, January 27, 2000

Copyright © 2004

Page 1 of 220
Next Page